Hematology - European Medical Journal

Continue

Hematology

Filter
EMJ
9 Mins
21 Feb 2022

The Search for Sustained Durability in Higher-Risk Myelodysplastic Syndrome: New Treatment Pathways in Sight

Higher-risk MDS is a collective term based on the Revised International Prognostic Scoring System (IPSS-R) that encompasses…
4 Mins
3 Feb 2022

Digital Necrosis in Multiple Myeloma

Multiple myeloma (MM) is a B cell malignancy characterised by abnormal proliferation of plasma cells that expand in the bone marrow…
12 Mins
31 Jan 2022

Updates on Isatuximab in Relapsed/Refractory and Newly Diagnosed Multiple Myeloma

In the past decade, therapies that are more effective and less toxic have transformed the treatment landscape for patients with MM…
6 Mins
24 Jan 2022

Atorvastatin, Aspirin, and Hydroxyurea Treating Polycythaemia Vera

The following highlights focus on several insightful and innovative abstracts at the European Hematology Association (EHA) 2022 hybrid…
9 Mins
15 Dec 2021

Optimising Outcomes in Cutaneous T Cell Lymphoma: Role of Blood Involvement and Treatment Options

CTCL is a rare type of non-Hodgkin lymphoma, primarily presenting in the skin but with extracutaneous involvement in some patients. Around…
14 Mins
13 Dec 2021

Genome Editing and CAR-T Cell Therapy

Recent efforts to incorporate genome editing into CAR T cell therapy offers novel opportunities for treatment of haematologic malignancies…
10 Mins
9 Dec 2021

Factor XI Inhibition: The Holy Grail of Haemostasis-Sparing Anticoagulation

Ajay Kakkar opened this virtual meeting by discussing the history of the treatment and prevention of thrombosis…
12 Mins
8 Dec 2021

Sickle Cell Disease: More Than Just Anaemia

Rachel Kesse-Adu highlighted that the hallmark of sickle cell disease (SCD) is painful vaso-occlusive crises (VOCs). These not only cause…
We’ve noticed you’re accessing
from North/South America.